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Abstract 
The aim of this study was to explore how cell-matrix interactions and extrinsic mechanical 
signals interact to determine stem cell fate in response to transforming growth factor-β3 
(TGF-β3). Bone marrow derived mesenchymal stem cells (MSCs) were seeded in agarose 
and fibrin hydrogels and subjected to dynamic compression in the presence of different 
concentrations of TGF-β3. Markers of chondrogenic, myogenic and endochondral 
differentiation were assessed. MSCs embedded within agarose hydrogels adopted a spherical 
cell morphology, while cells directly adhered to the fibrin matrix and took on a spread 
morphology. Free-swelling agarose constructs stained positively for chondrogenic markers, 
with MSCs appearing to progress towards terminal differentiation as indicated by mineral 
staining. MSC seeded fibrin constructs progressed along an alternative myogenic pathway in 
long-term free-swelling culture. Dynamic compression suppressed differentiation toward any 
investigated lineage in both fibrin and agarose hydrogels in the short-term. Given that fibrin 
clots have been shown to support a chondrogenic phenotype in vivo within mechanically 
loaded joint defect environments, we next explored the influence of long term (42 days) 
dynamic compression on MSC differentiation. Mechanical signals generated by this extrinsic 
loading ultimately governed MSC fate, directing MSCs along a chondrogenic pathway as 
opposed to the default myogenic phenotype supported within unloaded fibrin clots. In 
conclusion, this study demonstrates that external cues such as the mechanical environment 
can override the influence specific substrates, scaffolds or hydrogels have on determining 
mesenchymal stem cell fate. The temporal data presented in this study highlights the 




Bone marrow derived mesenchymal stem cells (MSCs) could potentially provide an 
effective cell source for tissue engineering and regenerative medicine applications. MSCs can 
differentiate along several pathways including the chondrogenic, osteogenic, adipogenic and 
myogenic lineages (Caplan, 1991). The ability to direct MSC differentiation in a stable and 
concerted manner is crucial to the success of tissue engineering and regenerative medicine 
therapies. In vivo MSC differentiation down distinct lineages is dependent on cues present in 
the local microenvironment. While much attention has centred on the use of soluble factors to 
direct MSC differentiation (Minguell et al., 2001; Pittenger et al., 1999), the role of insoluble 
signals such as cell shape (McBeath et al., 2004), cell adhesion (Connelly et al., 2008), 
substrate rigidity (Engler et al., 2006) and mechanical cues from the external environment 
(Huang et al., 2004) are also significant. 
It has long been proposed that mechanical signals can direct the differentiation of 
MSCs (Carter et al., 1988; Pauwels, 1960; Prendergast et al., 1997); a theory supported by in 
vitro bioreactor studies. In the absence of chondrogenic growth factors, dynamic compressive 
strain applied to hydrogel encapsulated MSCs has been shown to enhance chondrogenic gene 
expression (Huang et al., 2004; Li et al., 2010; Pelaez et al., 2009) and matrix synthesis 
(Kisiday et al., 2009; Li et al., 2010; Mauck et al., 2007). The response of MSCs to both 
biochemical and biophysical cues is more complex, with reports of the simultaneous 
application of  TGF-β3 and dynamic compression suppressing chondrogenic gene expression 
(Campbell et al., 2006; Haugh et al., 2011; Steinmetz and Bryant, 2011) and matrix 
accumulation in the early stages of differentiation (Huang et al., 2010; Thorpe et al., 2008). 
When cytokine mediated differentiation is permitted to occur prior to the application of 
dynamic compression, chondrogenic gene expression (Haugh et al., 2011; Mouw et al., 
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2007), matrix synthesis (Thorpe et al., 2010) and construct mechanical properties (Huang et 
al., 2010) are increased. 
Cell-matrix interactions also play a key role in regulating stem cell fate. Integrin 
mediated adhesion to the extracellular matrix has been shown to modulate both chondrogenic 
(Connelly et al., 2008) and osteogenic (Kundu et al., 2009) MSC differentiation, and may act 
as a means for mechanotransduction (Kock et al., 2009; Wang et al., 2009). One such natural 
hydrogel which facilitates integrin binding to ligands present on the scaffold is fibrin (Janmey 
et al., 2009). Fibrin has been shown to support chondrogenic differentiation (Li et al., 2009; 
Pelaez et al., 2009), but it similarly facilitates osteogenic (Catelas et al., 2006; Weinand et al., 
2006) and myogenic (Nieponice et al., 2007; O'Cearbhaill et al., 2010) differentiation of 
MSCs. 
The exact mechanisms of how biochemical and biophysical cues interact to determine 
stem cell fate within an environment that can potentially support differentiation along 
multiple pathways, such as a fibrin clot, have yet to be determined. In an in vitro setting, 
TGF-β has been shown to promote both chondrogenic (Johnstone et al., 1998; Mackay et al., 
1998) and myogenic (Jeon et al., 2006; Kinner et al., 2002) MSC differentiation. This switch 
between chondrogenic and myogenic fates in the presence of TGF-β has been shown to 
depend on matrix stiffness (Park et al., 2011) and cell shape (Gao et al., 2010). Adherent and 
well spread MSCs were shown to undergo myogenic differentiation in response to TGF-β3, 
while cells that were prevented from spreading and flattening underwent chondrogenic 
differentiation (Gao et al., 2010). In vivo, insoluble cues will be provided not only by the 
substrate and associated changes in cell shape, but also from the external mechanical 
environment. The aim of this paper is to explore how cell-matrix interactions and extrinsic 
mechanical signals interact to determine stem cell fate in response to TGF-β.  We first 
hypothesised that cell-substrate interactions in a three dimensional hydrogel would determine 
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MSC fate in response to TGF-β. Specifically, a hydrogel repressing cell adhesion and 
spreading (agarose) would encourage the chondrogenic differentiation of MSCs, while a 
hydrogel promoting cell spreading and cell-cell interactions (fibrin) would support a 
myogenic phenotype. We next explored how extrinsic mechanical signals, specifically 
dynamic compression of a substrate shown to support myogenesis, would influence stem cell 
fate. We hypothesised that the long-term application of dynamic compression would override 
the effects of the local substrate, suppressing myogenesis and enhancing chondrogenesis of 
MSCs. 
2. Methods
2.1 Cell isolation and expansion 
Porcine bone marrow-derived MSCs were isolated as mononuclear cells from the 
femora of 4 month old porcine donors (~50kg) within 2 hours of sacrifice and plated at 
10×106 cells in 75cm2 culture flasks (Nunclon; Nunc, VWR, Dublin, Ireland) to allow for 
colony formation. MSCs were maintained in high-glucose Dulbecco’s modified eagles 
medium (4.5 mg/mL D-Glucose, 200mM L-Glutamine; hgDMEM) supplemented with 10% 
foetal bovine serum (FBS), penicillin (100 U/mL)-streptomycin (100 μg/mL) (all GIBCO, 
Invitrogen, Dublin, Ireland) and amphotericin B (0.25μg/mL; Sigma-Aldrich, Arklow, 
Ireland) . Cultures were washed in Dulbecco’s phosphate buffered saline (PBS) after 72 hrs. 
When ~75% confluent, MSCs were re-plated at 5×103 cells/cm2 and expanded to passage two 
in a humidified atmosphere at 37°C and 5% CO2. 
2.2 Agarose and fibrin hydrogel encapsulation 
For agarose encapsulation, MSCs were suspended in defined chondrogenic medium 
(CM) consisting of hgDMEM supplemented with penicillin (100 U/mL)-streptomycin (100
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μg/mL) (both GIBCO), 100 KIU/mL aprotinin (Nordic Pharma, Reading, UK ), 0.25 μg/mL 
amphotericin B, 100 μg/ml sodium pyruvate, 40 μg/mL L-proline, 1.5 mg/mL bovine serum 
albumin, 4.7 μg/mL linoleic acid, 1× insulin–transferrin–selenium, 50 μg/mL L-ascorbic 
acid-2-phosphate and 100 nM dexamethasone (all Sigma-Aldrich). This cell suspension was 
mixed with agarose (Type VII; Sigma-Aldrich) in PBS at a ratio of 1:1 at ~40°C, to yield a 
final agarose concentration of 2% and a cell density of 15×106 cells/mL. The agarose-cell 
suspension was cast between stainless steel plates, allowed cool to 21°C for 30 min., and 
cored to produce cylindrical constructs (Ø 5mm×3mm thickness).  
For fibrin encapsulation, MSCs were suspended in 10,000 KIU/mL aprotinin solution 
(Nordic Pharma) containing 19 mg/mL sodium chloride and 100 mg/mL bovine fibrinogen 
type I-S (60-85% protein, ~10% sodium citrate and ~15% sodium chloride; Sigma-Aldrich), 
which was combined 1:1 with 5 U/mL thrombin in 40 mM CaCl2 (pH 7) and allowed to gel 
in an agarose mould for 45 min. at 37°C; producing cylindrical constructs (Ø 5mm×3mm 
thickness) with final concentrations of 50 mg/mL fibrinogen, 2.5 U/mL thrombin, 5,000 
KIU/mL aprotinin, 17 mg/mL sodium chloride, 20 mM CaCl2 and 15×106 cells/mL. 
Constructs were maintained in 2.5 mL CM with the addition of either 1 ng/mL or 10 ng/mL 
TGF-β3 (ProSpec-Tany TechnoGene Ltd., Israel). Media was exchanged every 3 or 4 days 
and sampled for biochemical analysis. The mechanical properties of both hydrogels were 
determined according to previous protocol (Buckley et al., 2009) and are presented in Table 
1. 
2.3 Dynamic compression application 
Dynamic compressive loading was applied to constructs as described previously 
(Thorpe et al., 2010). Intermittent dynamic compression (DC) was applied in an incubator-
housed, custom dynamic compression bioreactor, and consisted of a sine wave of 10% strain 
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amplitude superimposed upon a 1% pre-strain, with a 0.01 N per construct preload at a 
frequency of 1 Hz for 3 hours/day, 7 days/week for 21 days. MSC seeded fibrin constructs 
were additionally subjected to DC for 42 days, or delayed dynamic compression (DDC) 
where loading was applied from day 22 to day 42 of culture.   
2.4 Biochemical constituents 
Constructs were analysed at day 0 (24 hrs. after cell encapsulation), day 21 and day 
42. On removal from culture, construct diameter and wet weight (ww) were recorded and
constructs were frozen at -85°C for further analysis. Biochemical content was assessed at 
each time point as previously described (Thorpe et al., 2010). Samples were digested with 
papain (125μg/ml) in 0.1 M sodium acetate, 5 mM L-cysteine HCl, 0.05 M EDTA (all 
Sigma-Aldrich), pH 6.0 at 60°C under constant rotation for 18 hours. DNA content was 
quantified using the Hoechst Bisbenzimide 33258 dye assay (Sigma-Aldrich) as previously 
described (Kim et al., 1988). The sulphated glycosaminoglycan (sGAG) content was 
quantified using the dimethylmethylene blue dye-binding assay (Blyscan; Biocolor Ltd., 
Northern Ireland). Total collagen content was determined by measuring orthohydroxyproline 
via the dimethylaminobenzaldehyde and chloramine T assay (Kafienah and Sims, 2004). A 
hydroxyproline-to-collagen ratio of 1:7.69 was used (Ignat'eva et al., 2007). Cell culture 
media was analysed for sGAG and collagen as above, and alkaline phosphatase using a 
commercially available assay kit (Sensolyte pNPP Alkaline Phosphatase, Cambridge 
Biosciences, UK). 
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2.5 Cell viability and F-actin cytoskeleton fluorescent imaging 
MSC seeded constructs were sectioned to produce a cross section ~1 mm thick 
perpendicular to the disc face. To assess cell viability, sections were washed in PBS followed 
by incubation in PBS containing 4μM calcein AM (live cell membrane) and 4μM ethidium 
homodimer-1 (dead cell DNA; both Cambridge Bioscience, Cambridge, UK). Sections were 
again washed in PBS and imaged with a Carl Zeiss LSM 510 confocal laser scanning 
microscope. 
F-actin cytoskeletal filaments were visualised using rhodamine 110 conjugated
phalloidin (VWR). Constructs were sectioned as described above, fixed in 4% 
paraformaldehyde overnight and washed in PBS. Cells were permeabilised in 0.5% Triton-
X100 (Sigma-Aldrich), rinsed in PBS, and incubated for 1.5 hours in PBS with 1.5% BSA 
and rhodamine 110 conjugated phalloidin (1:40; 200 U/mL; VWR). Construct slices were 
again rinsed in PBS and imaged with a Carl Zeizz LSM 510 confocal laser scanning 
microscope. 
2.6 Histology and immunohistochemistry 
Constructs were fixed in 4% paraformaldehyde, paraffin embedded and sectioned at 5 
μm to produce a cross section perpendicular to the disc face. Sections were cleared in xylene, 
rehydrated, and stained for sGAG with 1% alcian blue 8GX in 0.1M HCl, for collagen with 
picro-sirius red, and for calcific deposition with 1% alizarin red (all Sigma-Aldrich). 
Histochemical assessment of alkaline phosphatase (ALP) activity was performed as 
previously described (Miao and Scutt, 2002). Deparaffinised hydrated tissue sections were 
incubated overnight in 1% magnesium chloride in 100mM tris-maleate buffer (pH 9.2) 
followed by incubation for 2 hours in ALP substrate solution consisting of 100mM tris-
maleate buffer (pH 9.2) containing 0.2 mg/mL naphthol AS-MX phosphate and 0.4 mg/mL 
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Fast Red TR (all Sigma-Aldrich). Sections were rinsed in de-ionized water and mounted in 
glycerol. 
The deposition of collagen type I, collagen type II, collagen type X and α-smooth 
muscle actin was identified through immunohistochemistry. Sections were enzymatically 
treated with chondroitinase ABC (Sigma-Aldrich) in a humidified environment at 37°C. Cell 
membranes were permeabilised in 0.1% Triton-X100. Slides were blocked with goat serum 
(Sigma-Aldrich) and sections were incubated for 1 hour with the primary antibody (all 
Abcam, Cambridge, UK) diluted in blocking buffer as specified in Table 2. After washing in 
PBS, sections were incubated for 1 hour in the secondary antibody, anti-mouse IgG biotin 
antibody produced in goat (1:133; 2 mg/mL; Sigma-Aldrich) followed by incubation for 1 
hour with ExtrAvidin-FITC (1:100; Sigma-Aldrich). Sections were washed several times in 
PBS, nuclei were counterstained with DAPI (1:500; 1 mg/mL; VWR), and sections mounted 
using Vectashield (Vector Laboratories, Peterborough, UK). Sections were imaged with an 
Olympus IX51 inverted fluorescent microscope fitted with an Olympus DP70 camera. 
2.7 RNA isolation and real-time reverse transcriptase polymerase chain reaction 
Quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) 
was used to determine the relative gene expression changes in chondrogenic and myogenic 
specific genes in response to the application of dynamic compression for 21 days. Total RNA 
was extracted from MSC seeded constructs following 21 days of culture. Constructs were 
harvested directly after the application of dynamic compression, snap frozen in liquid 
nitrogen, and stored at -85°C for later analysis. Total RNA was isolated from each construct 
via homogenisation using a rotor-stator homogeniser (Polytron PT 1200 E; Kinematica Inc, 
Switzerland) in 1 mL TRIzol® reagent followed by chloroform extraction with PureLink™ 
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RNA Mini Kit (Invitrogen). RNA was re-suspended in RNase-free water prior to reverse 
transcription. 
RNA concentrations were determined using the Quant-iT™ RNA assay and a Qubit® 
fluorometer. 100ng of RNA was reverse transcribed into cDNA using the High Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, Paisley, UK). Real-time PCR 
reactions were carried out in 20μL volumes containing 10μL 2× TaqMan® Universal PCR 
Master Mix, 5μL nuclease free water, 4μL cDNA template (1ng/μL) and 1μL 20× TaqMan® 
gene expression assay (primer/probes; FAM dye) as outlined in Table 3 (all Applied 
Biosystems). Reactions were carried out on an ABI 7500 real-time PCR system (Applied 
Biosystems) with an amplification profile of 50°C for 2 min., 95°C for 10 min., followed by 
40 cycles of denaturation at 95°C for 15 sec. and annealing/amplification at 60°C for 1 min. 
Quantitative expression of target genes relative to the endogenous control reference gene 
(GAPDH) and the FS calibrator was carried out using the  method as previously 
described (Livak and Schmittgen, 2001). 
2.8 Statistical analysis 
Presented are results from one of two replicate studies with unique donors, where n 
refers to the number of constructs analysed for each assay within a given replicate (n numbers 
provided in figure legends). Statistics were performed using MINITAB 15.1 software 
(Minitab Ltd., Coventry, UK). Where necessary, a Box-Cox transformation was used to 
normalise data sets. Construct groups were analysed for significant differences using a 
general linear model for analysis of variance with factors of hydrogel, TGF-β3 concentration, 
dynamic compression and interactions between these factors examined. Tukey’s test for 
multiple comparisons was used to compare conditions. Significance was accepted at a level 
of p≤0.05. Numerical and graphical results are presented as mean ± standard error. 
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3. Results
3.1 Hydrogel type modulates MSC response to TGF-β3 stimulation 
MSCs were encapsulated in agarose or fibrin hydrogels and cultured for 21 days in 
free-swelling unloaded conditions with the addition of either 1 ng/mL or 10 ng/mL TGF-β3. 
TGF-β3 concentration was investigated on account of the possibility that MSC response to 
either substrate or mechanical stimulation could be masked by the stimulus provided by 10 
ng/mL TGF-β3. At day 21, F-actin cytoskeletal filaments were stained with phalloidin as an 
indication of stress fibre formation and cell morphology. MSCs seeded in agarose adopted a 
spherical cell morphology with some processes evident at day 21, suggesting cell binding to 
elaborated pericellular matrix (Fig. 1). In fibrin constructs, cells adhered to integrin binding 
sites present on the fibrin matrix and adopted a spread morphology evident at day 21 (Fig. 1). 
Evidence of cell-cell interactions were also observed in fibrin that were generally absent in 
agarose hydrogels. Cell viability staining did not indicate any significant effect of hydrogel 
type or TGF-β3 concentration on live or dead cell numbers (not shown). 
The influence of hydrogel type coupled with TGF-β3 concentration on markers of 
chondrogenic, endochondral and myogenic differentiation was investigated. While sGAG 
accumulation and alcian blue staining increased with TGF-β3 concentration in agarose and 
fibrin (p<0.0001; Fig. 2A & 2B), agarose appeared to better support TGF-β3 mediated 
chondrogenesis; as evidenced by greater sGAG accumulation when supplemented with 
10ng/mL TGF-β3 (p<0.0001; Fig. 2A). Collagen type II immunofluorescence further 
confirmed this finding with agarose constructs staining more intensely than fibrin (Fig. 2C). 
Despite low collagen type II immunofluorescence in fibrin hydrogels, total collagen 
accumulation was superior in fibrin constructs (p<0.0001; Fig. 2A), which stained intensely 
for collagen type I (Fig 2C). 
12 
Alkaline phosphatase (ALP) secretion to the media and staining intensity was greater 
for agarose encapsulated MSCs than those in fibrin (p<0.0001; Fig. 2A & 2B). Though 
increased TGF-β3 concentration led to increased ALP secretion from agarose (p<0.001), the 
same effect was not observed from fibrin (Fig 2A). Pericellular collagen type X 
immunofluorescence was evident within the agarose constructs, especially at 1 ng/mL TGF-
β3 (Fig. 2C). This co-localised with regions of collagen type I (Fig. 2C) and calcific deposits 
indicated by alizarin red staining (Fig. 2B); providing evidence of endochondral ossification 
for agarose encapsulated MSCs in the presence of TGF-β3. Interestingly, regions of more 
intense ALP activity did not appear to co-localise with alizarin red staining (Fig 2B). In 
contrast to agarose, fibrin constructs stained negatively for collagen type X (Fig. 2C) and 
alizarin red (Fig. 2B). 
Myogenic differentiation was assessed with immunofluorescent staining for α-smooth 
muscle actin. While pericellular staining was evident at 1 ng/mL TGF-β3 in agarose 
constructs, this was not observed with increased TGF-β3 concentration (Fig. 2C). In contrast, 
a cell layer developed on the surface of fibrin constructs which stained intensely for α-smooth 
muscle actin and was independent of TGF-β3 concentration (Fig. 2C). When the culture 
period was extended to 42 days, the intensity of  α-smooth muscle actin staining in FS fibrin 
hydrogels increased while the staining for type II collagen diminished, indicating that fibrin 
hydrogels preferentially support myogenic differentiation over chondrogenic differentiation 
(Fig. 5). In addition, fibrin construct diameter reduced significantly with time for both TGF-
β3 concentrations, (~6% diameter reduction; p<0.001) suggesting the adoption of a 
contractile phenotype. 
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3.2 Dynamic compression suppresses both chondrogenesis and myogenesis in agarose and 
fibrin hydrogels when applied at the onset of TGF-β3 induced differentiation 
It has previously been shown that dynamic compression inhibits chondrogenesis of 
agarose encapsulated MSCs at early time points (Haugh et al., 2011; Thorpe et al., 2008). 
This inhibition may be modulated by cell attachment to the hydrogel matrix. Hence, it was 
initially hypothesised that substrate mediated alterations in cell shape and attachment would 
modulate the response to dynamic compression; specifically that such mechanical cues would 
not suppress chondrogenesis of MSCs embedded in fibrin constructs where cells can directly 
adhere to the hydrogel. To test this hypothesis, MSCs were encapsulated in both agarose and 
fibrin hydrogels and were cultured for 21 days in free swelling (FS) or dynamically 
compressed (DC) conditions. While the effect of TGF-β3 concentration coupled with DC was 
investigated, no significant interactions were found. DC exerted a similar response with 1 
ng/mL TGF-β3 as with 10 ng/mL TGF-β3; consequently only the 10 ng/mL TGF-β3 
condition is presented. Cell viability was unaffected by DC (data not shown). DC inhibited 
sGAG (p<0.0001) and total collagen (p<0.0001) accumulation in both agarose and fibrin 
constructs (Fig. 3A). Both collagen type I and type II staining intensities were reduced in 
response to DC (Fig. 3C). Furthermore, DC acted to inhibit collagen type X staining in 
agarose (Fig. 3C); leading to a subsequent inhibition of calcific deposits demonstrated 
through the absence of alizarin red stain (Fig. 3B). As stated above, no evidence of 
mineralisation was observed in fibrin constructs (Fig. 3B). In contrast, DC acted to increase 
ALP activity in both agarose and fibrin encapsulated MSCs as indicated by enzyme secretion 
to the media (p=0.0001; Fig. 3A) and histochemical staining (Fig. 3B). As DC also 
suppressed cartilage-specific matrix accumulation and mineralisation in agarose, one could 
infer that increased ALP activity in the absence of robust chondrogenesis is not indicative of 
an endochondral phenotype. In addition to inhibiting chondrogenic and endochondral 
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differentiation, DC repressed myogenesis. Though intense α-smooth muscle actin staining 
was present around the periphery of FS fibrin constructs, DC acted to completely inhibit this 
myogenic marker (Fig. 3C). Consequently, we were unable to provide support for our initial 
hypothesis that dynamic compression would not suppress differentiation of MSCs embedded 
in fibrin constructs where cells can directly adhere to the hydrogel. 
3.3 Extrinsic mechanical stimuli determine the eventual chondrogenic versus myogenic fate 
decision in MSC seeded fibrin constructs 
Fibrin appeared to initially support both a chondrogenic and a myogenic phenotype. 
Given that the mechanically loaded environment of a fibrin clot within an osteochondral 
defect and other in vivo regenerative environments often supports a chondrogenic phenotype, 
it was hypothesised that in the long-term, dynamic compression could direct MSCs toward a 
chondrogenic as opposed to a myogenic phenotype. This hypothesis was partially motivated 
by our previous studies which demonstrated that the application of dynamic compression to 
agarose encapsulated MSCs following 3 weeks of TGF-β3 induced differentiation enhances 
subsequent chondrogenesis (Haugh et al., 2011; Thorpe et al., 2010). To further probe the 
effect of dynamic compression on differentiation within fibrin hydrogels, constructs were 
harvested for analysis of gene expression using real time RT-PCR after 21 days in FS or DC 
culture with 10 ng/mL TGF-β3. DC of fibrin encapsulated MSCs had no effect on the 
chondrogenic genes Sry-related high mobility group box-9 (SOX9) and aggrecan (ACAN; 
Fig. 4). However, DC did up-regulate collagen type II (COL2A1) gene expression relative to 
FS controls (p=0.0011; Fig. 4). Gene expression for collagen type X (COL10A1), an 
endochondral marker, was expressed at low levels and was not modulated by DC (Fig. 4). 
This correlated with negative immuno staining for collagen type X in fibrin (Fig. 2C). 
Collagen type I (COL1A1), a marker of both osteogenic and myogenic differentiation was 
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down regulated in response to dynamic compression (p=0.0004; Fig. 4). Expression of 
myogenic markers, α-smooth muscle actin (ACTA2) and calponin-1 (CNN1) were strongly 
down-regulated in DC fibrin constructs (p=0.0001 & p=0.0286 respectively; Fig. 4); 
suggesting that DC inhibits myogenic differentiation. Gene expression of heavy chain 
myosin-1, a late marker of myogenic differentiation, was expressed at low levels in both FS 
and DC groups. 
We next explored how such changes in gene expression would impact markers of 
differentiation in the long-term. MSCs encapsulated in fibrin hydrogels were cultured for 42 
days with 10 ng/mL TGF-β3. Dynamically compressed (DC) constructs were subjected to 
daily dynamic compression from day 0 to day 42, while delayed dynamically compressed 
(DDC) constructs were cultured in FS conditions up to day 21, when daily dynamic
compression was initiated and continued until day 42. Dynamic compression from day 0 
(DC) led to an increase in the rate of sGAG accumulation from day 21 to day 42 compared to
FS controls (p<0.01, Fig. 5A), such that total accumulation was comparable to FS controls by 
day 42 (Fig. 5A). Initiation of dynamic compression at day 21 (DDC) had a positive effect on 
sGAG accumulation such that it was greater than both FS (p=0.0189) and DC (p=0.0356) 
constructs by day 42 (Fig. 5A). Immunofluorescent staining for collagen type II at day 42 
was markedly more intense for DC constructs than either FS or DDC constructs (Fig. 5C), 
correlating with the up-regulation of COL2A1 gene expression in response to dynamic 
compression at day 21 (Fig. 4). Moreover, collagen type II immunofluorescent staining was 
more intense in DDC constructs compared to FS controls which were negative for this 
chondrogenic marker (Fig 5C).  
As described above, long-term FS culture in fibrin hydrogels appeared to encourage a 
myogenic phenotype; apparent with strong staining for both α-smooth muscle actin and type I 
collagen (Fig. 5C). DC acted to inhibit myogenic differentiation. DC constructs had a larger 
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diameter than FS constructs at day 42 (p=0.0208) suggesting that DC suppresses cell-
mediated contraction, typical of myogenic differentiation. Collagen type I 
immunofluorescence was also reduced in DC constructs compared to both FS and DDC 
constructs at day 42 (Fig. 5C), while DC constructs stained negatively for α-smooth muscle 
actin (Fig. 5C). DDC constructs did exhibit faint staining close to the construct edge (Fig. 
5C). 
Although the total ALP secreted at day 42 did not differ across dynamic compression 
conditions, the temporal patterns of ALP secretion did (Fig. 5A). ALP secretion increased 
between days 21-42 compared with the first 21 days for FS (p=0.0002) and DDC (p=0.0004) 
constructs (Fig. 5A), while it decreased for DC constructs between days 21-42 (p<0.0001; 
Fig. 5A). In spite of this, there were no discernible differences in ALP enzyme activity 
staining across dynamic compression conditions (Fig. 5B) and all constructs stained 
negatively for both collagen type X and calcific deposition (not shown). 
 
4. Discussion 
The aim of the study was to explore how cell-matrix interactions and the external 
mechanical environment interact to regulate stem cell fate in response to TGF-β3. Agarose 
was found to support a spherical cell morphology and a chondrogenic phenotype, while fibrin 
facilitated a spread cell morphology, cell-cell interactions and stress fibre formation. Initially 
fibrin constructs stained positively for both chondrogenic and myogenic markers, but in the 
long-term this substrate supported a more myogenic phenotype; evident by strong staining for 
α-smooth muscle actin and the absence of type II collagen staining after 6 weeks of FS 
culture. However, the ultimate fate decision of the MSCs was not determined by the specific 
characteristics of the local substrate, but rather by the external mechanical environment. 
Initially dynamic compression suppressed differentiation along either pathway, but in the 
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long-term these mechanical signals directed the MSCs along a chondrogenic pathway as 
opposed to the default myogenic route supported by the uncompressed fibrin clot.   
In a free swelling environment, the fate decision of MSCs was determined by the 
local substrate. Unlike agarose (to which cells cannot directly adhere), fibrin facilitates 
integrin mediated cellular attachment through two pairs of RGD sites (Cheresh et al., 1989). 
Chondrogenic differentiation of MSCs has previously been shown to be repressed within 
RGD-modified agarose hydrogels (Connelly et al., 2008). More robust chondrogenesis was 
observed in agarose constructs where cells assumed a spherical morphology; while 
myogenesis was suppressed within these hydrogels. In contrast, myogenic differentiation was 
evident in fibrin constructs where MSCs took on a well spread morphology, with evidence of 
cell-cell interactions and the formation of F-actin stress fibres resulting in significant cell 
mediated hydrogel contraction. This is in general agreement with the findings of Gao et al. 
(2010) who demonstrated using  micropatterned substrates that a rounded cell shape led to an 
up-regulation of chondrogenic genes while a spread cell shape led to an up-regulation of 
myogenic genes in the presence of TGF-β3.  
To the best of our knowledge, differences between the two hydrogel types other than 
the availability of binding sites are less likely to explain the observed differences in MSC fate 
in free swelling conditions. The agarose hydrogels used in this study were stiffer than the 
fibrin hydrogels (Dynamic modulus: Agarose 50 kPa; Fibrin 31 kPa). While hydrogel 
modulus is a known regulator of stem cell fate when RGD binding sites are available 
(Huebsch et al., 2010), to the best of our knowledge there is no evidence to suggest that these 
differences in stiffness between agarose and fibrin constructs, in isolation, would explain our 
findings. Furthermore, no evidence of MSC differentiation was observed in constructs not 
supplemented with TGF-β3 (data not shown), suggesting that any soluble factors present in 
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the fibrin itself are unlikely to be driving the observed differences in MSC fate between the 
two hydrogels. 
Chondrogenically primed bone marrow MSCs have been shown to eventually 
undergo hypertrophy and endochondral ossification (Farrell et al., 2009; Hellingman et al., 
2010; Pelttari et al., 2006). The agarose hydrogels appeared to support an endochondral 
pathway for encapsulated MSCs, apparent in type X collagen staining, ALP activity and 
calcific deposits. No evidence of mineralisation or collagen type X was observed in fibrin 
constructs, suggesting that fibrin encapsulated MSCs may not have progressed sufficiently 
along the chondrogenic pathway to enable further differentiation toward an endochondral 
phenotype. 
Dynamic compression, initiated at the onset of differentiation, suppressed markers 
associated with the chondrogenic, myogenic and endochondral phenotypes. Suppression of 
chondrogenesis with dynamic compression in agarose hydrogels has been previously 
observed (Huang et al., 2010; Mouw et al., 2007; Thorpe et al., 2008). Both chondrogenic 
and osteogenic differentiation markers have been shown to be reduced in response to 
dynamic compression for MSCs encapsulated in RGD modified poly(ethylene glycol) 
hydrogels (Steinmetz and Bryant, 2011). Furthermore, dynamic compression has been shown 
to inhibit cartilage specific matrix production in chondrocyte seeded fibrin hydrogels (Hunter 
et al., 2004). The only marker increased by dynamic compression in the short-term in this 
study was ALP enzyme activity. This has been proposed as an in vitro marker suggestive of 
subsequent calcification (Dickhut et al., 2009), however in this case, increased ALP activity 
did not translate to calcification. Dynamic compression may be suppressing mineralisation 
through inhibition of chondrogenesis and the subsequent progression along the endochondral 
pathway. Alternatively, dynamic compression could be preventing differentiation towards 
hypertrophy, helping to maintain a more stable chondrogenic phenotype. Previous studies 
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have provided support for the hypothesis that mechanical cues suppress hypertrophy of 
chondrogenically primed MSCs (Bian et al., 2012; Steward et al., 2012; Vinardell et al., 
2012). 
While dynamic compression initially suppressed chondrogenesis in fibrin hydrogels, 
long-term dynamic compression was associated with increased expression of type II collagen. 
sGAG and total collagen accumulation increased between day 21 and 42 in response to 
continued dynamic compression while a concurrent decrease in ALP activity was observed. 
Moreover, accumulated collagen was predominantly collagen type II, in agreement with 
increased gene expression at day 21. Most noticeable however was the complete suppression 
of α-smooth muscle actin staining and the less intense collagen type I staining, as well as the 
down-regulation of α-smooth muscle actin (ACTA2) and calponin-1 (CNN1) gene 
expression, demonstrating that external mechanical loading was driving the MSC fate 
decision in fibrin constructs. At this stage the molecular mechanism through which dynamic 
compression regulates the myogenic versus chondrogenic fate decision in fibrin hydrogels is 
unclear. Cell shape has been shown to regulate this fate decision (Gao et al., 2010), although 
there was no strong evidence to suggest that dynamic compression is leading to a more 
spherical cell morphology in fibrin hydrogels. Gao et al. (2010) demonstrated that TGF-β3 
activated Rac1 and increased N-cadherin expression in spread cells, leading to the up-
regulation of myogenic genes. Dynamic compression could possibly impact at any point 
along this signalling cascade. For example, dynamic compression could potentially reduce 
the expression of N-cadherin or alter associations with N-cadherin at the cell membrane, such 
as N-cadherin and β-catenin association, which has previously been shown to be mechano-
regulated (Arnsdorf et al., 2009). If this were indeed the case, it could potentially explain the 
temporal response of MSCs to loading. N-cadherin is required for the initial cellular 
condensation at the onset of chondrogenesis (Oberlender and Tuan, 1994a), but its expression 
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diminishes as differentiation along this pathway progresses (Oberlender and Tuan, 1994b). If 
dynamic compression inhibits N-cadherin expression, it may explain the initial suppression of 
both myogenesis and chondrogenesis, leading to the long-term promotion of a chondrogenic 
phenotype. Further work is required to elucidate the molecular mechanism involved in this 
stem cell fate decision in response to dynamic compression. 
In conclusion, we have shown that MSC differentiation in response to TGF-β 
stimulation is dependent upon the hydrogel within which the cells are encapsulated. Perhaps 
more importantly, this study demonstrates that cues present in the in vivo environment,  such 
as extrinsic mechanical load, can override the influence of specific substrates, scaffolds or 
hydrogels that have been shown to modulate stem fate in an in vitro setting. The temporal 
data presented in this study highlight the importance of considering how MSCs respond to 
extrinsic mechanical signals in the long term. In the context of stem cell based therapies for 
tissue regeneration, it may be that the site specific mechanical environment is the ultimate 
regulator of phenotype and function. 
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Table/Figure Legends 
Table 1: Peak stress at 10% strain, equilibrium and 1 Hz dynamic moduli of agarose and 
fibrin hydrogels seeded with MSCs at 15×106 cells/mL. An unconfined stress-relaxation test 
was carried out with a ramp to 10% strain at 1 μm/s followed by 30 min. relaxation with 
subsequent cyclic testing from 10% to 11% strain at 1 Hz. *: p<0.001 vs. Fibrin. 
Table 2: Primary antibodies and controls used for immunohistochemistry. 
Table 3: TaqMan® primer/probes used for real-time PCR. 
Figure 1. MSC seeded agarose and fibrin constructs were cultured for 21 days in FS 
(unloaded) conditions with the addition of either 1 ng/mL or 10 ng/mL TGF-β3. Cytoskeletal 
F-actin filaments in day 21 constructs were stained with rhodamine 110 conjugated
phalloidin. (n = 2) Scale bar: 20 μm. 
Figure 2. The influence of hydrogel substrate and TGF-β3 concentration on markers of 
chondrogenic, endochondral and myogenic differentiation after 21 days culture. A: sGAG 
(top) and total collagen (middle) construct biochemical content, and alkaline phosphatase 
(ALP) secreted to the media (bottom) (n = 4). B: Histological staining of constructs with 
alcian blue for sulphated mucins, picro sirius red for total collagen, naphthol phosphate with 
fast red for ALP enzyme activity and alizarin red for calcific deposition (n = 2). C: 
Immunofluorescent staining for collagen type I, collagen type II, collagen type X and α-
smooth muscle actin (green) with nucleus counterstained with DAPI (blue) (n = 2). Scale bar: 
500 μm; inset scale bar: 50 μm. 
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Figure 3. The influence of dynamic compression and hydrogel substrate on markers of MSC 
chondrogenic, endochondral and myogenic differentiation after 21 days culture with 10 
ng/mL TGF-β3. A: sGAG (top) and total collagen (middle) construct biochemical content, 
and alkaline phosphatase (ALP) secreted to the media (bottom) (n = 4). B: Histological 
staining of constructs with alcian blue for sulphated mucins, picro sirius red for total 
collagen, naphthol phosphate with fast red for ALP enzyme activity and alizarin red for 
calcific deposition (n = 2). C: Immunofluorescent staining for collagen type I, collagen type 
II, collagen type X and α-smooth muscle actin (green) with nucleus counterstained with 
DAPI (blue) (n =2). Scale bar: 500 μm; inset scale bar: 50 μm. 
Figure 4. Dynamic compression was applied to fibrin encapsulated MSCs in the presence of 
10 ng/mL TGF-β3 for 21 days with chondrogenic, myogenic and endochondral gene 
expression assessed at day 21. Dynamically compressed construct gene expression is 
presented relative to the free-swelling control. FS: Free-swelling; DC: Dynamic compression 
(n = 4). 
Figure 5. The influence of long-term dynamic compression on markers of MSC chondrogenic 
and myogenic differentiation after 42 days culture in fibrin hydrogel with 10 ng/mL TGF-β3. 
A: sGAG accumulated (top), collagen accumulated (middle), and alkaline phosphatase (ALP) 
secreted to the media (bottom) from days 0-21, days 21-42 and days 0-42 (n = 4). B: 
Histological staining of constructs with alcian blue for sulphated mucins, picro sirius red for 
total collagen, and naphthol phosphate with fast red for ALP enzyme activity (n = 2). C: 
Immunofluorescent staining for collagen type I, collagen type II and α-smooth muscle actin 
(green) with nucleus counterstained with DAPI (blue) (n = 2). Scale bar: 500 μm; inset scale 













Hydrogel Peak stress[kPa] Equilibrium modulus [kPa] 1 Hz Dynamic modulus [kPa] 
Agarose 2.174±0.060 11.003±0.756* 49.981±0.741* 




Antigen Primary Antibody Positive Control Negative Control 
Collagen I Monoclonal mouse (1:400; 1 
mg/mL) 
Porcine ligament Porcine articular 
cartilage 





Collagen X Monoclonal mouse (1:200; 1.4 
mg/mL) 
Porcine growth plate Porcine ligament 
α-smooth 
muscle actin 
Monoclonal mouse (1:75; 0.2 
mg/mL) 










Glyceraldehyde-3-phosphate dehydrogenase GAPDH Ss03373286_u1 83 
SRY (sex determining region Y)-box 9 SOX9 Ss03392406_m1 145 
Aggrecan ACAN Ss03374822_m1 96 
Collagen, type II, alpha 1 COL2A1 Ss03373344_g1 106 
Actin, alpha 2, smooth muscle, aorta ACTA2 Ss04245588_m1 84 
Calponin 1, basic, smooth muscle CNN1 Ss03392449_g1 83 
Myosin, heavy chain 1, skeletal muscle, adult MYH1 Ss03818758_s1 71 
Collagen, type I, alpha 1 COL1A1 Ss03373340_m1 74 
Collagen, type X, alpha 1 COL10A1 Ss03391766_m1 85 
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